7617-70-1

Basic information

• Product Name: Benzaldehyde, 4-(2-bromoethyl)-
• CAS NO: 7617-70-1
• Molecular Formula: C9H9BrO
• Molecular Weight: 213.074
• Mol File: 7617-70-1.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-(2-bromoethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-(2-bromoethyl)-(7617-70-1)
• EPA Substance Registry System: Benzaldehyde, 4-(2-bromoethyl)-(7617-70-1)

Safety Data

• Hazardous Substances Data: 7617-70-1(Hazardous Substances Data)

Upstream product

• 5312-73-2 dichloromethyl n-butyl ether 
• 103-63-9 1-phenyl-2-bromoethane 
• 24249-98-7 p-chloromethyl-2-bromoethylbenzene 
• 52062-92-7 4-(2-bromoethyl)benzoic acid 
• 4885-02-3 Dichloromethyl methyl ether 

Downstream Products

• 1622143-73-0 1-(2-chloroethyl)-4-(dimethoxymethyl)benzene 
• 1622143-72-9 1-(2-bromoethyl)-4-(dimethoxymethyl)benzene 
• 934753-51-2 ethyl 8-(4-cyanophenyl)-6-formyloctanoate 
• 934737-83-4 methyl 4-[4-(4-cyanophenyl)-2-formylbutyl]benzoate 
• 934753-50-1 ethyl 8-(4-cyanophenyl)-6-hydroxymethyloctanoate 
• 934737-82-3 methyl 4-[4-(4-cyanophenyl)-2-hydroxymethylbutyl]benzoate 
• 934753-49-8 2-[2-(4-cyanophenyl)ethyl]heptanedioic acid 7-ethyl ester 
• 934737-81-2 methyl 4-[2-carboxy-4-(4-cyanophenyl)butyl]benzoate 
• 934753-05-6 methyl (E)-4-[2-[2-(4-cyanophenyl)ethyl]-4-(2-hydroxyphenyl)but-3-enyl]benzoate 
• 934753-52-3 ethyl E-6-[2-(4-cyanophenyl)ethyl]-8-(2-hydroxyphenyl)oct-7-enoate 
• 934753-48-7 1-Allyl 7-ethyl 2-allyloxycarbonyl-2-[2-(4-cyanophenyl)ethyl]heptandioate 
• 934737-79-8 diallyl 2-[2-(4-cyanophenyl)ethyl]-2-(4-methoxycarbonylbenzyl)malonate 
• 935253-25-1 Methyl 4-{(3E)-4-{2-[(2-chlorobenzyl)oxy]phenyl}-2-[2-(4-cyanophenyl)ethyl]but-3-en-1-yl}-benzoate 

Relevant articles and documents

KINASE MODULATORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

Provided herein are kinase modulators, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disease, disorder, or condition associated with a protein malfunction.

SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS

The present invention relates to substituted diaryl azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.

Aerobic oxidation of benzylic halides to carbonyl compounds with molecular oxygen catalyzed by tempo/kno2 in aqueous media

Benzylic halides were successfully oxidized to the corresponding aldehydes and ketones in good to excellent yields in aqueous media with molecular oxygen as oxidant in the presence of catalytic amounts of TEMPO (2,2,6,6- tetramethylpiperidyl-1-oxy) and potassium nitrite (KNO2).